BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 33121211)

  • 41. Amide Proton Transfer Imaging in Predicting Isocitrate Dehydrogenase 1 Mutation Status of Grade II/III Gliomas Based on Support Vector Machine.
    Han Y; Wang W; Yang Y; Sun YZ; Xiao G; Tian Q; Zhang J; Cui GB; Yan LF
    Front Neurosci; 2020; 14():144. PubMed ID: 32153362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.
    De Looze C; Beausang A; Cryan J; Loftus T; Buckley PG; Farrell M; Looby S; Reilly R; Brett F; Kearney H
    J Neurooncol; 2018 Sep; 139(2):491-499. PubMed ID: 29770897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of
    Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.
    Choi YS; Bae S; Chang JH; Kang SG; Kim SH; Kim J; Rim TH; Choi SH; Jain R; Lee SK
    Neuro Oncol; 2021 Feb; 23(2):304-313. PubMed ID: 32706862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravoxel incoherent motion magnetic resonance imaging in predicting IDH1 gene mutations in high-grade gliomas.
    Wang C; Dong H
    Acta Radiol; 2021 Oct; 62(10):1412-1417. PubMed ID: 33951927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas.
    Pei D; Guan F; Hong X; Liu Z; Wang W; Qiu Y; Duan W; Wang M; Sun C; Wang W; Wang X; Guo Y; Wang Z; Liu Z; Xing A; Guo Z; Luo L; Liu X; Cheng J; Zhang B; Zhang Z; Yan J
    Eur Radiol; 2023 May; 33(5):3455-3466. PubMed ID: 36853347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences.
    Qin JB; Liu Z; Zhang H; Shen C; Wang XC; Tan Y; Wang S; Wu XF; Tian J
    Med Sci Monit; 2017 May; 23():2168-2178. PubMed ID: 28478462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [
    Li Z; Kaiser L; Holzgreve A; Ruf VC; Suchorska B; Wenter V; Quach S; Herms J; Bartenstein P; Tonn JC; Unterrainer M; Albert NL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4415-4425. PubMed ID: 34490493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
    Li Y; Liang Y; Sun Z; Xu K; Fan X; Li S; Zhang Z; Jiang T; Liu X; Wang Y
    Neuroradiology; 2019 Nov; 61(11):1229-1237. PubMed ID: 31218383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
    Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
    Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting isocitrate dehydrogenase status among adult patients with diffuse glioma using patient characteristics, radiomic features, and magnetic resonance imaging: Multi-modal analysis by variable vision transformer.
    Usuzaki T; Inamori R; Shizukuishi T; Morishita Y; Takagi H; Ishikuro M; Obara T; Takase K
    Magn Reson Imaging; 2024 Sep; 111():266-276. PubMed ID: 38815636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET.
    Tatekawa H; Hagiwara A; Uetani H; Bahri S; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Pope WB; Salamon N; Ellingson BM
    Cancer Imaging; 2021 Mar; 21(1):27. PubMed ID: 33691798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular subtype classification of low-grade gliomas using magnetic resonance imaging-based radiomics and machine learning.
    Lam LHT; Do DT; Diep DTN; Nguyet DLN; Truong QD; Tri TT; Thanh HN; Le NQK
    NMR Biomed; 2022 Nov; 35(11):e4792. PubMed ID: 35767281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
    Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM
    Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
    Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
    J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI.
    Hagiwara A; Tatekawa H; Yao J; Raymond C; Everson R; Patel K; Mareninov S; Yong WH; Salamon N; Pope WB; Nghiemphu PL; Liau LM; Cloughesy TF; Ellingson BM
    Sci Rep; 2022 Jan; 12(1):1078. PubMed ID: 35058510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging.
    Hashido T; Saito S; Ishida T
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):606-613. PubMed ID: 34270479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.